Pfizer launches Pneumococcal Conjugate Vaccine for adults in India
Single-dose PCV20 approved for adults 18 years and older, covering 20 pneumococcal serotypes including both invasive and…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Vaccines
India’s bio-economy can reach $ 300 bn, potentially doubling its growth from 2024
Indian Bio-Economy Report 2024 by the Association of Biotechnology Led Enterprises (ABLE) highlights India’s current bioeconomy,…
Zydus, supported by Gates Foundation, to develop combination vaccine against shigellosis and typhoid
This combination of vaccines, if found successful, will safeguard children against two lethal enteric diseases of global…
Zydus launches India’s first flu vaccine for southern hemisphere 2025 strain
VaxiFlu-4 developed as per WHO-recommended composition for influenza protection
Mankind Pharma completes acquisition of BSV
This acquisition strengthens Mankind's leadership in the fertility drug market and grants access to BSV's R&D-driven biologics…
Revised pharmacovigilance guidance for human vaccines open for public consultation
Stakeholders are invited to provide feedback on CDSCO draft guidance within 15 days from the notice's issuance
On May 29, 2024…
Altamira Therapeutics partners with Univercells Group on nanoparticle-delivered mRNA vaccines
Under the terms of the agreement, Univercells will test in vitro and in vivo a proprietary mRNA vaccine delivered with Altamira’s…
IIL launches its measles and rubella vaccine
This live attenuated MR vaccine has been developed by IIL in an exclusive partnership with Polyvac Institute, Vietnam
China’s CanSino seeks more vaccine contracts after AstraZenca deal
CanSino begun researching mRNA technology in 2018 and has built a facility in Shanghai that can produce up to 200 million doses a…
SII’s MenFive receives WHO prequalification
MenFive is currently undergoing an additional Phase 3 study in healthy children between 9 and 15 months of age in Mali, to examine…